Javier Gonzalo-Ruiz

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer

J. Tabernero, P. Nuciforo, R. Dienstmann, 2022, Nature Medicine.

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

E. Felip, S. Cedrés, A. Navarro, 2023, Molecular oncology.